Papers

Health inequalities and social dynamics in Europe

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7510.186 (Published 21 July 2005) Cite this as: BMJ 2005;331:186
  1. Denny Vågerö, professor (denny.vagero{at}chess.su.se)1,
  2. Mall Leinsalu, lecturer2
  1. 1 Centre for Health Equity Studies (CHESS), Stockholm University/Karolinska Institutet, SE-106 91 Stockholm, Sweden
  2. 2 Stockholm Centre on Health of Societies in Transition, Södertörn University College, SE-141 89 Huddinge, Sweden
  1. Correspondence to: D Vågerö

    Lawlor and colleagues make the valid point that health inequalities are dynamic and change over time and between countries.1 Unexpectedly, in Estonia and Portugal they found that a high level of insulin resistance is more common among children of more highly educated parents. They ask whether this is because of the new wealth of these families, perhaps a preference for Western style “junk” food?

    A well known, but often ignored, fact is that the social distribution of risk factors, disease, and mortality varies by disease entity, time period, and country. “Anomalies,” or deviations from the standard pattern of poorer people having poorer health, include breast cancer and malignant melanoma. Certain risk factors for heart disease, such as smoking or obesity, may previously have been more common among people who are wealthy; in some countries this is still so. Studies from several countries suggest that as coronary heart disease became more common, its inverse class pattern among men became more pronounced, perhaps even preceded by a reversal some decades ago.2 Similarly, the generally higher mortality rate ratios for circulatory diseases (comparing manual and non-manual workers) in northwestern Europe than in southern Europe may be a result of a “phase difference,” implying that those ratios will soon increase in the south.3 Is what the authors report from Portugal, Estonia, and Denmark consistent with such a phase transition? We feel that this is more likely to be the case for Portugal (Madeira) than for Estonia (Tartu).

    Health inequalities are indeed constantly changing, driven by the social dynamics of a country. Many paradoxes are hidden in this truth. For Russia, the standard pattern of mortality by education applies to both men and women, in spite of contrasting risk factor distributions, with many “anomalies”—for instance, in obesity and lipid profiles among men.4 For Estonia, highly educated adults, compared with those with less education, gained a considerable advantage during the 1990s, in terms of mortality from circulatory diseases and total mortality.5 According to Lawlor and colleagues, the children of these highly educated parents may paradoxically have the poorest insulin resistance profile. We cannot say how much of a paradox this really is, however, as we know nothing about whether their parents as children also had a poor insulin profile.

    Genetic, fetal, and early childhood factors should all be relevant in determining insulin resistance. In Lawlor and colleagues' study, parental education was important for insulin resistance among prepubertal and postpubertal children. Parental education can be taken as a measure of social circumstances when their children were born—that is, before the collapse of the Soviet system. Income was measured in 1997-2000; for Estonia this means when new food markets had opened up. In mutual adjustments, education but not income had an independent effect; thus it seems unlikely that it is consumption of “burgers, crisps, and processed food” that is creating the pattern of high insulin resistance among children of highly educated parents. We also noted that, in this study, children of highly educated fathers in Estonia had a 200 g lower birth weight than others, consistent with their higher insulin resistance.

    Anomalies such as those reported for Estonia and Portugal may be of special significance, as they point towards gaps in our understanding and warn against too simplistic a view of health inequalities. Correctly understanding the development of health and mortality in the formerly communist led countries of central and eastern Europe is likely to challenge (and has already challenged) many cherished epidemiological “truths.”

    Footnotes

    • We thank Ilona Koupil for important comments to a previous version of this commentary.

    • Contributors DV wrote the first version. ML commented and suggested changes. Both authors have read and accepted the final version.

    • Funding DV is financed through the Swedish Council for Working Life and Social Research. ML is financed through the Swedish Foundation for Baltic and East European Studies.

    • Competing interests None declared.

    References

    1. 1.
    2. 2.
    3. 3.
    4. 4.
    5. 5.
    View Abstract